ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.629,64
-0,44%
S&P 500
5.222,68
0,16%
US Dollar vs BRL
5,1561
0,27%
Bitcoin
60.784,91
-3,59%
Brent Oil
82,70
-1,49%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Cempra (CEMP)

  7. Cempra (CEMP) Notícias

CEMP

Cempra (CEMP)

Cempra
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CEMP
DataHoraFonteTítuloCódigoCompanhia
03/08/202009:00GlobeNewswire Inc.Melinta Therapeutics Announces Appointment of Christine Ann Miller as President and Chief Executive OfficerNASDAQ:CEMPCempra
07/02/201809:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CEMPCempra
26/01/201819:47Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:CEMPCempra
22/01/201820:20Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:CEMPCempra
19/01/201820:17Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:CEMPCempra
12/01/201816:29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CEMPCempra
11/01/201820:08Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CEMPCempra
11/01/201820:05Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CEMPCempra
10/01/201809:12Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:CEMPCempra
09/01/201821:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CEMPCempra
09/01/201819:26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CEMPCempra
08/01/201820:21Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CEMPCempra
05/12/201720:29Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:CEMPCempra
04/12/201711:19Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CEMPCempra
16/11/201719:35Edgar (US Regulatory)Statement Regarding Change in Majority of Directors Pursuant to Rule 14f-1 (sc 14f1)NASDAQ:CEMPCempra
13/11/201720:11Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CEMPCempra
13/11/201719:39Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CEMPCempra
03/11/201713:59GlobeNewswire Inc.Cempra Announces Preliminary Results of 2017 Stockholder Vote NASDAQ:CEMPCempra
02/11/201718:22Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CEMPCempra
01/11/201709:00GlobeNewswire Inc.Melinta and Cempra Announce Accomplished Executive Leadership Team for Combined OrganizationNASDAQ:CEMPCempra
31/10/201709:00GlobeNewswire Inc.Melinta and Cempra Name Industry Leader Daniel Wechsler as President and Chief Executive Officer of the Combined CompanyNASDAQ:CEMPCempra
24/10/201710:00GlobeNewswire Inc.Melinta Therapeutics Publication Reinforces Baxdela Tolerability and Activity in Patients with MRSA Infections and Challengin...NASDAQ:CEMPCempra
10/10/201709:00GlobeNewswire Inc.Melinta Therapeutics’ Topical Radezolid Well Tolerated in Phase 1 Study for Treatment of AcneNASDAQ:CEMPCempra
05/10/201707:11Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:CEMPCempra
04/10/201714:14GlobeNewswire Inc.Melinta Therapeutics Presents Outcomes of Baxdela Treatment of Gram-Positive and Gram-Negative Pathogens at IDWeekNASDAQ:CEMPCempra
28/09/201717:15GlobeNewswire Inc.Cempra and Melinta Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed MergerNASDAQ:CEMPCempra
25/09/201709:00GlobeNewswire Inc.Melinta Therapeutics Presenting Detailed Analyses from Baxdela Phase 3 ABSSSI Trials and In Vitro Performance against Isolate...NASDAQ:CEMPCempra
10/09/201709:45PR Newswire (US)SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Cempra, Inc. -- CEMPNASDAQ:CEMPCempra
07/09/201717:15GlobeNewswire Inc.Cempra Announces Presentations at Upcoming Investor Conferences and Provides Merger Process UpdateNASDAQ:CEMPCempra
07/09/201707:05Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:CEMPCempra
 Apresentando as notícias mais relevantes sobre:NASDAQ:CEMP

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
VVEO3
CM Hospitalar ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
PRIO3
PETRORIO ON
BOV
LUPA3
LUPATECH ON
BOV
AZEV4
AZEVEDO PN
BOV
COGN3
COGNA ON
BOV
OIBR3
OI ON
BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
UNIP6
UNIPAR PNB
BOV
HAGA3
HAGA ON
BOV
TELB4
TELEBRAS PN
BOV
SGPS3
SPRINGS ON
BOV
PDTC3
Padtec ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados